Yutaka Kakizoe, Terumasa Nakagawa, Yasunobu Iwata, Qinyuan Deng, Masataka Adachi, Yoshikazu Miyasato, . . . Masashi Mukoyama. (2022). Camostat mesilate, a serine protease inhibitor, exerts aquaretic effects and decreases urinary exosomal AQP2 levels. Elsevier.
Chicago Style (17th ed.) CitationYutaka Kakizoe, et al. Camostat Mesilate, a Serine Protease Inhibitor, Exerts Aquaretic Effects and Decreases Urinary Exosomal AQP2 Levels. Elsevier, 2022.
MLA (9th ed.) CitationYutaka Kakizoe, et al. Camostat Mesilate, a Serine Protease Inhibitor, Exerts Aquaretic Effects and Decreases Urinary Exosomal AQP2 Levels. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.